Bioanalytical Methods - June 27-28, 2005 - Philadelphia, PA

Bioanalytical Methods
Current Strategies for Macromolecule and Assay Characterization, Development, and Validation
June 27-28, 2005 - Philadelphia, PA
Airport Marriott
Topics Include:
Identify Bioanalytical Method Validation Requirements, Standards, Current Trends,
Future Challenges, and Government Regulations
Perform Cross-Validation for Effective Method Transfers
Implement Practical Approaches to the Design and Validation of Cell-Based Assays
Used for the Detection of Anti-Drug Neutralizing Antibodies
Evaluate Protein Stability and Separation Methods by Means of Chromatographic
Techniques
Develop Statistical Considerations of Bioanalytical Method Characterization
Learn Project Management for Assay Development
Understand a Fit-for-Purpose Approach for Quantitative Method Development and
Validation of Novel Biomarkers
Review Principles of Bioanalytical Method Development and Validation
Comprehensive Coverage from Industry Experts:
Eli Lilly & Company
Pfizer
Amgen
Bristol-Myers Squibb
Covance Laboratories Inc.
Michael K. Li Consulting
United States Pharmacopeia
ASI Ltd.
Genyzme Corporation
Drexel University
Tanox, Inc.
AAI Development Services
DSE Consulting, Inc.